In the present study, the pro-survival role and underlying mechanism of PERK-eIF2α-ATF4-P21 signaling are explored, and PERK inhibitor GSK2656157 is shown to enhance the anti-tumor effects of MPPα-PDT in HOS cells via regulation of autophagy by p21. This evidence concerns the gene CDKN1A and neoplasm.